Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-4.94 Insider Own0.10% Shs Outstand375.25M Perf Week-1.34%
Market Cap81.11B Forward P/E13.52 EPS next Y15.98 Insider Trans1.67% Shs Float374.51M Perf Month11.80%
Income-1948.30M PEG- EPS next Q3.73 Inst Own88.40% Short Float6.05% Perf Quarter-6.98%
Sales14.90B P/S5.44 EPS this Y23.00% Inst Trans-0.07% Short Ratio4.40 Perf Half Y-10.87%
Book/sh215.93 P/B1.00 EPS next Y19.42% ROA10.30% Target Price260.11 Perf Year-27.74%
Cash/sh73.00 P/C2.96 EPS next 5Y12.26% ROE18.70% 52W Range184.50 - 301.98 Perf YTD2.92%
Dividend2.80 P/FCF34.26 EPS past 5Y-50.40% ROI-1.30% 52W High-28.43% Beta1.07
Dividend %1.30% Quick Ratio3.90 Sales past 5Y33.40% Gross Margin83.30% 52W Low17.15% ATR5.27
Employees31200 Current Ratio4.00 Sales Q/Q4.40% Oper. Margin-9.80% RSI (14)64.52 Volatility2.83% 2.37%
OptionableYes Debt/Eq0.39 EPS Q/Q52.20% Profit Margin94.40% Rel Volume0.76 Prev Close216.24
ShortableYes LT Debt/Eq0.37 EarningsFeb 08 BMO Payout0.00% Avg Volume5.15M Price216.14
Recom2.00 SMA205.02% SMA508.25% SMA200-4.91% Volume3,889,860 Change-0.05%
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Jan-16-17 01:00AM  Allergan, Schlumberger, IBM: Doug Kass' Views
Jan-14-17 05:59AM  Jobless Claims and Trimming GLD: Best of Kass
Jan-12-17 02:45PM  Pharma company executives debate drug pricing increases
02:00PM  Lawsuit accuses Shire of monopolizing market for ADHD drug at bizjournals.com
08:00AM  Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast PR Newswire
Jan-11-17 07:01PM  Cramer: Trump Doesn't Seem to Care About the Trump Rally
04:16PM  Correction: Drug Prices-Johnson & Johnson story
02:22PM  Mylan CEO Heather Bresch says keeping drug price hikes below 10% isnt the answer at MarketWatch
01:26PM  Trump's Comments Are Big Pharma's Nightmare at Forbes
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:26PM  Trump's Comments Are Big Pharma's Nightmare
08:36AM  Allergan Shifts Strategy to Focus on Growth at TheStreet
Jan-10-17 08:01PM  Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
04:51PM  Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation
04:06PM  5 Manufacturing Stocks With 25% Upside Potential
12:59PM  Todd Hagopian's Top Biotech Takeover Targets For 2017 at Forbes
12:45PM  Allergan CEO: Seeing constructive movement by entire indu...
09:09AM  Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes at Motley Fool
Jan-09-17 03:47PM  AGN Makes Two Small Deals at Investopedia
03:05PM  Allergan wants to buy a Cambridge biotech founded by ex-Genzyme CEO at bizjournals.com
11:21AM  Teva Pharmaceutical Industries Ltd -- Moody's: Operating Headwinds Weigh On Teva's 2017 Deleveraging Plans -- A Credit Negative at Moody's
11:13AM  [video]Allergan Continues Down 'Stepping Stone' Path With Two Deals
08:30AM  Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs PR Newswire
08:00AM  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs GlobeNewswire
07:39AM  Teva Falls on Disappointing 2017 Sales & Earnings Guidance
01:00AM  Allergan, Google, Oaktree Capital: Doug Kass' Views
Jan-07-17 03:03PM  These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
Jan-06-17 09:00PM  Craft a Strategy From Retail's Wreckage: Best of Kass
08:09PM  Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
04:22PM  ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers
03:26PM  Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway? at Barrons.com
01:26PM  Allergan CEO on the Hot Seat: Here's What He Had to Say at Motley Fool
07:24AM  Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View
Jan-05-17 04:01PM  Allergan Pops On 2017 Guidance; Can It Survive Alzheimer's Rivalries?
03:38PM  Allergan: No More "Aspirational" Financial Guidance at Barrons.com
12:52PM  Cooperman's best ideas: 14 stock picks
11:19AM  Allergan Is Playing Its Cards Close To The Vest at Investopedia
10:07AM  Saunders Paints Realistic Outlook for Allergan in 2017
08:57AM  Allergan issues 2017 guidance, expects double-digit EPS growth at MarketWatch
08:29AM  How Trump-related uncertainty is bringing out the health-care stock bears at MarketWatch
08:16AM  Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
07:52AM  Allergan expects mid-single digit 2017 revenue growth
07:30AM  Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook PR Newswire
06:45AM  What Pharma and Healthcare Investors Should Watch For at JPM Next Week
Jan-04-17 11:14AM  Allergan Plc (AGN) Explodes After FDA Approval Of Natrelle Inspira at Insider Monkey
08:33AM  Allergan Natrelle Inspira Breast Implants Approved in the U.S.
07:35AM  FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg PR Newswire
Jan-03-17 07:20PM  Abraham, Fruchter & Twersky, LLP Files Securities Class Action Lawsuit Against Allergan PLC (NYSE: AGN) Marketwired
04:15PM  Allergan to Present at 35th Annual J.P. Morgan Healthcare Conference PR Newswire
02:42PM  New year, new drug prices
12:32PM  Allergan Drug Price Hikes Are in Effect, Though Increases Are Modest at TheStreet
11:01AM  Allergan Continues 2017 Where It Left Off In 2016 at Investopedia
10:31AM  EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN PR Newswire
09:48AM  Allergan took its pricing pledge last fall about as literally as it gets at MarketWatch
07:35AM  Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants PR Newswire
Jan-02-17 10:25AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses In Excess of $100,000 of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
01:00AM  Starbucks, Allergan, Amazon: Doug Kass' Views
Dec-30-16 01:15PM  Apollo Endosurgery Shares Up 20% After Going Public With Reverse Merger
11:15AM  3 Sleeper Biotechs That Could Bounce Back Strong in 2017
10:30AM  GPM Reminds Investors of the January 3 Deadline in the Class Action Lawsuit Against Allergan PLC Business Wire
08:58AM  Apple and Microsoft: Moving Opposite on Share Buybacks?
08:00AM  Brent Saunders's New Model Will Be Tested in 2017 at Bloomberg
07:35AM  Analyzing Mercks General Medicine and Womens Health Segment
Dec-29-16 04:19PM  Bulls Are Pushing Allergan Shares Higher at Investopedia
10:10AM  DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) & Lead Plaintiff Deadline: January 3, 2017 GlobeNewswire
07:00AM  Healthcare: What Does a Trump Administration Mean for Healthcare Stocks? at Morningstar
Dec-28-16 03:42PM  January 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Allergan PLC Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
03:05PM  DEADLINE ALERT: Brower Piven Reminds Investors Of The January 3, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Allergan plc To Contact The Firm - AGN GlobeNewswire
09:06AM  VRXs Gastrointestinal Segment Saw Robust Revenue Growth in 2016
06:52AM  Biotech plays for the new year
Dec-27-16 02:13PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Allergan plc To Contact The Firm Before Lead Plaintiff Deadline Accesswire
11:53AM  Shares of Allergan Showing Positive Momentum at Investopedia
11:00AM  Biotech Poised for Rebound
10:02AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
Dec-26-16 09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
Dec-25-16 10:05PM  Asian stocks lower in light trading after Christmas
Dec-23-16 07:01PM  Cramer: Count Your Blessings, It's OK to Like Stocks Again
04:48PM  ALLERGAN ALERT: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action Filed by Firm - AGN GlobeNewswire
04:37PM  US stocks inch higher in slow pre-holiday trading
04:04PM  Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
02:52PM  Allergan Is Gaining Traction -- Plus Jim Cramer's Take
09:30AM  The Zacks Analyst Blog Highlights: FedEx, Verizon, Morgan Stanley, Caterpillar and Allergan
08:35AM  Ironwood, Allergan Report Positive Linzess IBS-C Study Data
05:48AM  Pharma Stock Roundup: J&J Back in Talks with Actelion, Teva Settles Corruption Probe
Dec-22-16 03:00PM  Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients PR Newswire
01:33PM  Top Research Reports for FedEx, Verizon & Morgan Stanley
11:20AM  Cambridge's Ironwood reports positive data on constipation drug at bizjournals.com
10:08AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
07:00AM  Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS Business Wire
07:00AM  Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C Business Wire
Dec-21-16 01:06PM  Allergan: Why LifeCell Deal is a 'Christmas Miracle!' at Barrons.com
11:39AM  Allergan's a Bargain That Could Pop 20%
09:56AM  Allergan to Buy LifeCell For $2.9 Billion at Investopedia
08:16AM  Allergan to Buy LifeCell to Boost Regenerative Medicine Suite
07:30AM  Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference PR Newswire
Dec-20-16 03:45PM  San Antonio biotech firm sells unit for $2.9 billion at bizjournals.com
12:15PM  Why Biogen's new CEO stands to gain from an acquisition at bizjournals.com
10:32AM  Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion
10:30AM  Allergan to buy Acelity's tissue unit LifeCell for $2.9 bln
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM